top of page

TBnet news February 2024



Today, Thursday 29 February, 17:00 CET: our second webinar in 2024

The webinar entitled "Operational research on modified shorter treatment regimens for MDR/RR-TB in the WHO European Region: results and programmatic impact on burden of DR-TB".


More information about the webinar and the link to join:

Please note that in 2024 the webinars will be held every last Thursday of the month at 17:00 CET (instead of 16:00 CET).

 

Another webinar this week: UCL-TB webinar

Access to drugs for TB: Mapping issues, finding solutions webinar

A UCL-TB event to discuss anti-TB treatment access challenges across different settings Friday 1st March, 15:00 GMT (16:00 CET).


Despite the development of new drugs, and trials to support more effective treatment regimens for TB, cure cannot be achieved without access to medicines.

Drug pricing, access policies and patent issues are often responsible for inequalities in getting access to lifesaving medicines to people that need most. This webinar aims to describe those issues, identify the parts of the process most relevant to resolve, and the specific problems with individual drugs.  Two talks from experts in the field will be followed by discussions with panel members from different institutions across the world.


The webinar is organized by the UCL-TB in collaboration with TBnet.

 

TBnet photo competition

World TB Day is nearly here! To mark the occasion of the discovery of Mycobacterium tuberculosis, and the advancements that followed, TBnet will be holding a photo competition. TBnet members are welcome to participate, and there will be prizes available for the best entries!


More information will follow soon via email and on X (@TBnet_EU), Facebook (@TBnet) and LinkedIn (@TBnet_EU). We look forward to seeing all the amazing work our members are involved in reflected in these photos!

 

TBnet Academy 2024 – applications now open!

We are very happy to announce that the application for the 2024 TBnet Academy, held from May 26 to May 29 in Athens, Greece, is now open.


TBnet Academy is a wonderful opportunity to be in contact with your peers from different geographic regions of Europe and to learn about the latest developments in the fields of tuberculosis and NTM-infections from experienced colleagues.


If you are a young researcher/clinician and have interest in tuberculosis, consider applying.

The deadline for application is March 3rd.

 

Now, some news from NTMnet (Nontuberculous Mycobacteria Network European Trials Group)


NTMnet meeting at ECCMID, Barcelona

We are delighted to announce the first since long NTMnet meeting.

  • Date/time: Sun 28th April 2024 from 16:00-17:15 CEST.

  • Venue: ECCMID conference centre, room 8.28 + 8.29 (CC8 Upper floor).

A programme will be communicated shortly on our renewed website.


NTMnet website

Check out our refurbished website at http://www.ntm-net.org/ for most recent updates.


Get in touch with us through info@ntmnet.org. Enquiries, suggestions, remarks – all are welcome!

We look forward collaborating with this vibrant community, promoting NTM research and strengthening NTM knowledge.


On behalf of the NTMnet Steering Committee

 

Dr Berit Lange appointed to the STIKO

The German Federal Ministry of Health (Bundesministerium für Gesundheit) has appointed new members to the Standing Committee on Vaccination (STIKO). Among the 19 experts is Dr Berit Lange, acting head of the Epidemiology department at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the member of the TBnet Steering Committee. The STIKO is an independent, voluntary committee of experts with the aim of developing vaccination recommendations for the population in Germany. TBnet is proud to have Berit among us. Congratulations!

 

DZIF Clinical Tuberculosis Course 2024

The DZIF Clinical Tuberculosis Course 2024 invites clinicians, practitioners, scientist, public health workers, and colleagues from allied disciplines to provide latest updates on the prevention, diagnosis and treatment of tuberculosis and to provide a discussion forum with world leading experts on TB management, control and elimination.

It is an honor to announce the 2024 Visiting Professor in Tuberculosis at the Research Center Borstel, Dr. Zarir Udwadia, from Mumbai, India. In his keynote lecture he will address the situation of tuberculosis in India, where more than ¼ of people currently affected by this disease live.

In a satellite workshop, Dr. Leonardo Martinez from Boston, USA, will present practical aspects of conducting and evaluating systematic reviews and meta-analyses. The workshop is limited to 15 fellows: First come - first serve. Be cordially invited to join us in Borstel during the middle of the summer!

 

UNITE4TB Core Outcome Set survey

What outcomes matter most in studies of pulmonary TB treatments?

The University of Liverpool and UNITE4TB are conducting a survey that can shape the way TB research is conducted. Please take part in the survey if you are a TB researcher, healthcare worker, TB survivor, or part of the TB community/civil society.

Your opinion matters!


 

Results of phase 2a evaluation of ganfeborole (GSK3036656), a new antituberculous drug

The results of the phase 2a evaluation of ganfeborole (GSK3036656), a new antituberculous drug, are published in Nature Medicine. Currently this drug is being evaluated in phase 2b/c trials within UNITE4TB and other platforms.


Diacon, A.H., Barry, C.E., Carlton, A. et al. A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nat Med (2024). https://doi.org/10.1038/s41591-024-02829-7

 

Request for Information to inform development of the FY 2026-2030 NIH Strategic Plan for HIV and HIV-Related Research

Through this Request for Information, the Office of AIDS Research (OAR) in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), National Institutes of Health (NIH), invites feedback from researchers, health care professionals, advocates and health advocacy organizations, scientific or professional organizations, federal/state/local government agencies, community, and other interested constituents on the development of the fiscal year 2026-2030 NIH Strategic Plan for HIV and HIV-Related Research (the Plan). The Plan guides the NIH investment, building on scientific progress and opportunities for advancing HIV/AIDS research toward an end to the pandemic.


 

Your last chance to apply for positions at the regional committees of the International Union Against Tuberculosis and Lung Diseases

Are you based in Europe or North America? Both regional committees are looking for a member in their region to join their committee.

The European region membership committee has an available position for its Secretary General. The North America regional committee is seeking applications for the position of Secretary-Treasurer.


You can find more information and download the application form: https://mailchi.mp/theunion/updates-from-some-of-our-membership-groups-724765

 

TBnet News

Editor – Irina Kontsevaya

Layout & formatting – Liga Rusman

Cover picture – Irina Kontsevaya



 

271 views0 comments

Recent Posts

See All

Commentaires


bottom of page